A fundamental challenge in the transfusion of red blood cells (RBCs) is that a subset of donated RBC units may not provide optimal benefit to transfusion recipients. This variability stems from the inherent ability of donor RBCs to withstand the physical and chemical insults of cold storage, which ultimately dictate their survival in circulation. The loss of RBC deformability during cold storage is well-established and has been identified as a potential biomarker for the quality of donated RBCs. While RBC deformability has traditionally been indirectly inferred from rheological characteristics of the bulk suspension, there has been considerable interest in directly measuring the deformation of RBCs. Microfluidic technologies have enabled single cell measurement of RBC deformation but have not been able to consistently distinguish differences between RBCs between healthy donors. Using the microfluidic ratchet mechanism, we developed a method to sensitively and consistently analyze RBC deformability. We found that the aging curve of RBC deformability varies significantly across donors, but is consistent for each donor over multiple donations. Specifically, certain donors seem capable of providing RBCs that maintain their deformability during two weeks of cold storage in standard test tubes. The ability to distinguish between RBC units with different storage potential could provide a valuable opportunity to identify donors capable of providing RBCs that maintain their integrity, in order to reserve these units for sensitive transfusion recipients.
Introduction
Donated red blood cells (RBCs) are a central component of critical patient care with >85 million units transfused globally per year 1 . A fundamental challenge in the transfusion of donated RBCs is that not all donated RBC units can confer the same benefits to recipients 2, 3 . Specifically, transfusion specialists have long been aware that certain RBC units are able to circulate for long periods of time in recipients to maintain hemostasis, while other units are rapidly cleared, leading to the need for repeat transfusions [4] [5] [6] [7] [8] . This situation is highly undesirable for chronic transfusion recipients because of potential adverse effects, such as iron-overload, transfusion related acute lung injury (TRALI), hypervolemia, and increased risk of infections [9] [10] [11] [12] . Consequently, there is a strong impetus to establish robust biomarkers to identify donors that could provide long circulating RBC units in order to match them to the clinical needs of the patient 13, 14 .
An essential characteristic of RBCs is their deformability, which enables these cells to transit through the microvasculature. The loss of deformability causes RBCs to be retained in the narrow inter-endothelial clefts of the spleen 15 , where they are subsequently removed from circulation 16 .
During cold storage, it is well-established that donated RBCs lose their deformability as a part of the storage lesion 13, [17] [18] [19] [20] [21] . While the storage lesion can contribute to a host of cellular changes, including depletion of 2,3-DPG 22 , cytoskeletal remodeling 23 , lipid oxidation 24, 25 , and membrane vesiculation 26, 27 , these effects independently as well as cumulatively contribute to the irreversible depletion of RBC deformability. Consequently, the deformability of RBC has long been considered as a potential biomarker for the quality of donated RBCs.
Existing methods for measuring RBC deformability include flow-based methods and deformationbased methods. Flow-based methods, including ektacytometry 28, 29 and related microfluidic approaches [30] [31] [32] , use shear stress generated in fluid flow to stretch RBCs in order to measure their elongation via diffraction or high-speed imaging. These approaches measure the rheological properties of RBCs during high-speed flow rather than the deformation of individual RBCs into the splenic microvasculature, which is the primary mechanism for RBC clearance. Deformation based methods include the traditional methods for single cell manipulation and recent microfluidic devices. Traditional single cell manipulation, including micropipette aspiration 33, 34 , optical tweezers 35 , and atomic force microscopy 36 , involve technically challenging experiments that require skilled personnel and highly specialized equipment. Microfluidic approaches for deformation based RBC deformability analysis include the measurement of capillary obstruction 37 , wedging in tapered constrictions 38, 39 , transiting time through constrictions [40] [41] [42] [43] , and transiting pressure through constrictions 17, 44, 45 . While these approaches greatly simplified RBC deformability analysis, the throughput of these processes are still relatively limited. Therefore, a frequent criticism is potential bias arising from the cell sampling process. Furthermore, microfluidic deformation approaches often rely on precise geometry of a small number of microscopy features, which can vary from device to device. Consequently, previous methods are typically used to assay the loss of RBC deformability due to pathologies or chemical treatment, but not to assess variability between healthy individuals.
Recently, we developed a microfluidic device to sort RBCs based on deformability using a matrix of asymmetrical constrictions that form microfluidic ratchets [46] [47] [48] . Key advantages of this device are the ability to apply consistent forces to each cell as it deforms across each constriction, as well as the ability to process a large number of cells 48 . These characteristics improve the consistency and throughput of single cell deformation measurements by averaging the measurement across large numbers of individual RBCs. Leveraging this capability, we show deformability based cell Donor-dependent Red Cell Aging 4 sorting using microfluidic ratchets provides a highly sensitive and consistent measurement of RBC deformability. Specifically, this measurement is capable of detecting distinct and temporally consistent differences between blood units from healthy donors, which we observed to exhibit donor-specific aging rates during cold storage.
The ability to detect differences in RBC deformability between healthy donors, as well as the loss of integrity during cold storage, provides a potential opportunity to identify donors who may provide RBCs that maintain their integrity during cold storage. This capability will be extremely important for chronic transfusion recipients that require long-circulating RBC units in order to reduce the number of transfusions. Reserving high-quality RBC units for these patients will improve outcomes and increase the overall blood supply.
Results

Microfluidic device design
The microfluidic ratchet device sorts RBCs based on deformability by deforming each cell through a series of tapered constrictions. (Fig. 1A) . Due to the geometric asymmetry of the taper, the force required to deform cells through the constriction along the direction of taper is less than against the direction of taper 46 . Coupling this deformation asymmetry with an oscillatory flow creates a ratcheting effect that selectively transports cells based on their ability to squeeze through each microscopic constriction. Importantly, this oscillatory flow also minimizes the contact between cells and the filter microstructure to prevent clogging and fouling and to ensure that a consistent filtration force is applied to each cell 47 .
To sort cells using this mechanism, a RBC sample is introduced at the bottom-left corner of a 2D array of micrometer-scale tapered constrictions. The openings of the constrictions are gradually decreased from the bottom row to the top row, forcing RBCs to deform as they transit through progressively smaller pores. The RBCs are transported through the array by a vertical oscillatory flow as well as a consistent horizontal cross flow, which combine to propel the cells in a zigzag diagonal path through the constriction matrix ( Fig. 1B) . As cells reach their limiting constriction that prevent their transport, they proceed horizontally along the terminal row until reaching a specific outlet (Fig. 1C) . The microfluidic device used to sort RBCs from healthy donors is designed to sort RBCs into 12 outlets. The constriction matrix is housed in a 4 µm thick microchannel. The size of the constrictions ranges from 1.50 µm to 3.50 µm in steps of 0.25 µm for outlets 1-9, and then from 3.50 µm to 7.50 µm in greater steps for outlets 10-12 ( Table 1 ). The 4 µm thick microchannel largely exclude leukocytes, debris and cell aggregates. However, if these artefacts enter the sorting area, they are sorted into the least deformable outlets, e.g. 10-12. As a result, we have not found evidence for nucleated cells or cell clusters in outlets 1-9. This device is capable of sorting ~600 RBCs per minute. The distribution of cells after sorting could be determined by imaging the flow of cells into the outlets or by counting the cells in the outlet via microscopy.
RBC rigidity score
After deformability-based cell sorting, the distribution of RBCs in outlets 1-12 can be shown as a histogram, where the loss of RBC deformability results in a rightward shift in distribution ( Fig.   2A ). In order to effectively compare differences between samples, we can plot the result as a cumulative distribution, and then define a "rigidity score" as the outlet where the cumulative distribution function crosses 50%. A fractional value for the rigidity score can be obtained by linear interpolation between data points in the cumulative distribution function. For example, the deformable and rigid RBC samples have rigidity scores of 2.45 and 4.87 respectively ( Fig. 2B) .
Process characterization and validation
We performed a series of studies to characterize the consistency and variability in our RBC sorting process. To characterize device-to-device variations, we used our process to sort 1.54 and 3.43 µm polystyrene calibration beads. The 1.53 µm beads were sorted into outlets 2 and 3, while the 3.43 µm beads were sorted into outlet 9. Similar results were obtained from 8 different devices, where the mean rigidity score for the 1.53 µm beads were 2.60 ± 0.24 (Fig. 3A) . We then evaluated the consistency of the sorting process on human RBCs. We sorted RBCs from a single donor simultaneously using 5 different devices. The RBC distribution were also highly consistent, where Donor-dependent Red Cell Aging 7 the rigidity score for this sample was 2.63 ± 0.17 ( Fig. 3B) . Together, these data show that the device fabrication process is robust and that the experimental process yield consistent results.
To establish that the rigidity score could discriminate between RBC populations with a range of cell deformability, we obtained fresh RBCs and applied mild glutaraldehyde (GTA) fixation in order to induce controlled rigidification of the cells. Following 30 minute GTA fixation, a dosedependent rightward shift could be observed in the distribution of RBCs within the device outlets, following sorting ( Fig. 3C) . Compared to the control (rigidity 2.63 ±0.17), GTA-fixed cells displayed rigidity scores of 3.6 (0.010% GTA), 8.0 (0.0125% GTA), 9.5 (0.015% GTA) and 10.7 (0.025% GTA).
Donor-based variability in RBC deformability
Having established sensitivity and consistency, we used our cell sorting approach to characterize donor-based variability in RBC deformability at the time of collection with 8 donors. Fresh RBCs are typically sorted into outlets 2-3 with some variability in their distribution. The 8 donors had a mean rigidity score 2.90 ± 0.4, ranging between 2.36 (donor 1) and 3.59 (donor 5) ( Fig. 4A) . To establish whether donor deformability profiles remained consistent over time, RBCs were collected from donors 1 and 5 on two more occasions, with at least 6 weeks between each sampling ( Fig. 4B) . Interestingly, the measured rigidity of RBCs for each donor was highly consistent for samples collected at each distinct occasion. Specifically, the rigidity score for donor 1 ranged from 2.36 to 2.57, while Donor 5 ranged from 3.19 to 3.59.
Donor-based variability in RBC deformability aging curves
To establish whether cell sorting using the microfluidic ratchet device could provide a robust method to measure the degradation of RBCs during cold storage, we measured the loss of deformability associated with the storage of RBCs in a standard plastic tube, which provide a more consistent model of accelerated aging over 14 days compared to a blood bag 49 . Donated blood samples from all 8 donors were stored in standard 15 ml plastic test tubes (Corning) for 14 days at 4°C. Deformability based cell sorting was performed on day 0, 3, 7, and 14. Interestingly, while all samples showed some loss of RBC deformability during cold storage (mean rigidity score change = +1.0), there was significant variability between donors ( Fig. 5) . Specifically, donor 1 showed the most significant loss of deformability during cold storage (+2.51 in rigidity score), even though this donor had the most deformable RBCs at the point of collection (rigidity score = 2.36). Whereas RBCs from donor 5 and donor 8 were remarkably stable, where the rigidity score is essentially unchanged (-0.04 and +0.25 for donor 5 and 8 respectively, Fig. 6 ).
Having observed that fresh RBC deformability was consistent for each donor, we investigated whether the RBC aging curve was also donor-specific when blood was collected on different occasions. RBC samples were collected from donors 1 and 5 at 6-week intervals and RBC deformability profiles were assessed over the course of storage to establish the RBC aging curve.
Consistent with our observation that RBC rigidity was temporally consistent for each donor, we also observed that the aging curve was remarkably consistent when sampled on different occasions ( Fig. 7) . Donor 1 consistently showed an accelerated RBC aging curve, while donor 5 consistently provided RBCs that retain their integrity during cold storage.
Hematological parameters do not affect RBC sorting
We also measured standard hematological indices during storage, including RBC mean corpuscular volume (MCV), red blood cell distribution width (RDW-CV), mean cell hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), using the SYSMEX® system.
There was a trend of increasing RBC MCV and MCHC during storage in the plastic tubes over the 14 days, while the RDW-CV and MCH remained largely unchanged (Table S1 ). However, these parameters all remained within the normal range during storage. Furthermore, linear regression analysis of these parameters and RBC rigidity score, did not show any significant correlations ( Fig.   S1 ).
Discussion
In this study we employed the microfluidic ratchet mechanism to sort RBCs from healthy donors based on deformability. After sorting, the RBCs in each outlet were counted and the distribution of cells was used to establish a rigidity score for the RBC population. Using this approach, we found that the baseline RBC deformability varies significantly between donors, but is relatively consistent for the same donor over multiple donations. Importantly, we found the RBC aging curve during cold storage, as defined by the loss of RBC deformability, is also heterogeneous, but consistent for each donor. These results collectively suggest RBC deformability measurements performed by sorting using the microfluidic ratchet could be used to identify donors capable of providing RBCs that maintain their integrity during cold storage.
RBC deformability is a key part of the mechanism for splenic clearance of RBCs 50,51 , and has therefore been frequently proposed as a potential biomarker for estimating the clearance time of transfused RBCs 52, 53 . Traditional methods, such as ektacytometry 28, 29, 54, 55 , test the rheological properties of RBC derived from bulk flow, which does not correlate well with circulatory clearance time 56, 57 . Microfluidic technologies present the potential to improve upon this measurement process by using microfabricated structures to approximate the deformation mechanics of the splenic microvasculature [58] [59] [60] . However, key limitations of existing microfluidic devices is the throughput of the measurement process, as well as sample-to-sample consistency. Using the microfluidic ratchet mechanism to perform continuous deformability-based cell sorting, we greatly increased measurement throughput. Importantly, by significantly increasing redundancy of the microstructure, we showed our process to be highly consistent and repeatable. The ability to perform consistent high-throughput measurement of RBC deformability will permit the study of the relationship between RBC deformability and circulation time, using approaches such as the recovery rate of 51 Cr-or biotin-labeled RBCs in transfused animal models [61] [62] [63] [64] .
RBC deformability measured using the microfluidic ratchet revealed significant inter-donor variability of freshly collected RBCs as well as inter-donor variability in RBC rigidification during storage. Interestingly, while previous efforts have reported storage-mediated mechanical deterioration of RBCs, deformability of fresh RBCs has largely been reported to be invariant 56, 57 .
Together, inter-donor variability in RBC deformability of both fresh and stored RBCs supports epidemiological evidence that RBC transfusion and storage efficacy is donor-dependent [65] [66] [67] [68] [69] .
While the data obtained in this study are too limited to derive associations between RBC deformability and transfusion efficacy, the observation that individual donors exhibit distinct and consistent RBC deformability before and during storage enables future studies to correlate donor RBC deformability and aging curves, as well as genetic, biochemical, and hematological rheological parameters, with clinical outcomes and the frequency of adverse events posttransfusion. An association between donor RBC deformability and transfusion efficacy could lead to the stratification of donors based on transfusion and RBC storage potential.
The identification of donors that can consistently provide high quality RBCs could have a profound impact on transfusion medicine. RBC units with a longer predicted circulation time could be matched to chronic transfusion recipients in order to reduce the frequency of transfusions and thereby, reduce transfusion-related morbidities, including iron-overload, hypervolemia, transfusion related acute lung injury (TRALI), as well as potential infection [9] [10] [11] . Furthermore, the ability to predict the circulation time of RBCs based on cell deformability could provide new methods of quality control in order to improve quality and reduce excessive outdating. In sum, the ability to match donated RBC units with the most appropriate recipient will translate to improved outcomes for sensitive recipients and optimal usage of this limited resource.
Methods
RBC sample collection, storage, and preparation
Only donors self-identified as healthy and between the ages of 18 and 70 were included in this study. Following informed consent and in accordance with University of British Columbia Research Ethics Board guidelines (UBC REB H19-01121), whole blood was collected from healthy donors via venipuncture into sodium citrate tubes (BD Vacutainer). The blood samples were leuko-reduced by first centrifuging at 3180 g for 10 minutes to decant plasma. The packed cells were then centrifuged at 677 g for 30 minutes with no brakes to remove the leukocytes. Each 
Microfluidic ratchet device manufacture
The microfluidic ratchet devices were prepared as described previously 70, 71 . Briefly, the master The composite structure was then bonded to a 75 x 50 mm glass slide (Corning) substrate using air plasma.
Microfluidic device operation
The microfluidic ratchet device is operated using a horizontal crossflow and oscillatory (forward/reverse) pressure system. Prior to loading the RBC sample, the device is primed by infusion with HBSS with 0.2% Pluronic-F127 solution, through the forward and oscillatory pressure system inlets at high pressure (200-250 mBar) for 15 min. The RBC sample for each assay is suspended at 1% hematocrit and then infused into the constriction matrix using a pressure of 40-45 mBar through the sample inlet port. The sample is then flowed through the constriction matrix using a horizontal crossflow pressure of 55-60 mBar, and oscillatory pressures of 175 mBar forward and 162 mBar reverse (Fig. 1) . The forward oscillatory pressure is applied for 4 seconds, while the reverse oscillatory pressure is applied for 1 second. The crossflow pressure is adjusted visually within the pressure range to ensure the equal distribution of cells within the sample inlet as well as a consistent application of upward pressure to each cell. The throughput of the sorting process is approximately 600 cells per minute. From the constriction matrix, the RBC sample is flowed into 12 outlets. The distribution of cells after sorting can be counted via video analysis of the microchannels leading to the outlets, or by imaging the outlets. The sorted RBCs could also be collected by pipetting.
Microbead sorting experiments
Polystyrene microbeads were sorted using the microfluidic ratchet device in order to establish the consistency across different microfluidic devices. Polystyrene beads with diameters of 1.53 µm Each bead suspension was then sorted for at least 20 minutes. The number of beads in each outlet fraction was quantified using the TrackMate particle analysis plug-in with Image J 73 .
RBC sorting experiments
Blood from a healthy donor was collected in a sodium citrate tube (BD Vacutainer), and RBCs were isolated as previously described above. The sample was then resuspended in HBSS and 0.2% Pluronic F127 solution to 1% hematocrit for further sorting with the microfluidic ratchet device.
The sample from the same donor and suspension was run on 5 separate devices from different production batches. Sorted fractions were quantified using TrackMate particle analysis plug-in with Image J, as previously described.
Glutaraldehyde fixation sorting experiments
In order to establish the sensitivity of the microfluidic ratchet device in measuring small changes in the deformability, RBCs from a healthy donor were collected in sodium citrate tubes (BD Vacutainer) and leuko-reduced as described above. The isolated RBCs were then washed three times and suspended at 10% hematocrit in HBSS with 0.02% Pluronic F127. These suspensions were fixed with either 0% (PBS control), 0.010%, 0.0125%, 0.015%, or 0.025% fresh glutaraldehyde (Cat # G5882, MilliporeSigma) for 30 minutes at room temperature. After fixation, the suspensions were washed three times in HBSS with 0.2% Pluronic F127 and then suspended at 1% Hct for the deformability experiment. The number of cells in each sorted fraction was quantified with the TrackMate particle analysis plug-in with Image J.
Statistical Analysis
Deformability and rigidity score data were analysed with GraphPad Prism (v6.0h) software. Mean with standard deviation (SD) were plotted unless otherwise stated. Linear regression analysis with 95% confidence intervals were used to determine correlations between data sets. Linear regression analysis (solid lines) showed that donor 1 (blue) had consistent loss of deformability during storage (R 2 =0.768, p=0.0002), while donor 5 (red) showed no differences between Day 0 and Day 14 of storage (R 2 =0.032, p=0.5799). 
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